Trastuzumab Active Not Recruiting Phase 2 Trials for Cancer, Breast Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01570036Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
NCT02297698Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients